Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.10USD
1.55 MUSD
111.61 MUSD
7.36 M
About COSMO PHARM N
Sector
CEO
Alessandro Della Chà
Headquarters
Dublin
Website
Founded
2016
ISIN
NL0011832936
FIGI
BBG00FBD5NH1
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CMOPF is 80.00 USD — it has increased by 4.44% in the past 24 hours. Watch Cosmo Pharmaceuticals NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Cosmo Pharmaceuticals NV stocks are traded under the ticker CMOPF.
Cosmo Pharmaceuticals NV is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
CMOPF stock is 4.25% volatile and has beta coefficient of 1.56. Track Cosmo Pharmaceuticals NV stock price on the chart and check out the list of the most volatile stocks — is Cosmo Pharmaceuticals NV there?
Yes, you can track Cosmo Pharmaceuticals NV financials in yearly and quarterly reports right on TradingView.
CMOPF net income for the last quarter is −158.10 K USD, while the quarter before that showed 1.64 M USD of net income which accounts for −109.67% change. Track more Cosmo Pharmaceuticals NV financial stats to get the full picture.
Today Cosmo Pharmaceuticals NV has the market capitalization of 1.26 B, it has increased by 0.72% over the last week.
Yes, CMOPF dividends are paid annually. The last dividend per share was 1.12 USD. As of today, Dividend Yield (TTM)% is 1.44%. Tracking Cosmo Pharmaceuticals NV dividends might help you take more informed decisions.
Like other stocks, CMOPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cosmo Pharmaceuticals NV stock right from TradingView charts — choose your broker and connect to your account.
CMOPF reached its all-time high on Jul 31, 2017 with the price of 160.68 USD, and its all-time low was 41.50 USD and was reached on Oct 17, 2023. View more price dynamics on CMOPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cosmo Pharmaceuticals NV technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cosmo Pharmaceuticals NV stock shows the buy signal. See more of Cosmo Pharmaceuticals NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Cosmo Pharmaceuticals NV future price: according to them, CMOPF price has a max estimate of 118.54 USD and a min estimate of 86.26 USD. Watch CMOPF chart and read a more detailed Cosmo Pharmaceuticals NV stock forecast: see what analysts think of Cosmo Pharmaceuticals NV and suggest that you do with its stocks.